Memo to the clueless from the big 3

[Anonymous]

http://www.biotronik.com/files/95F5AC507236018CC12578CC00523A72/$FILE/PR_BIOFLOW-II_EN_final.pdf

Bottom line, this is 2ish years on the market in Europe and after trying paclitaxel, the bioabsorble orsior is a sirolimus(market leading DES) system.

This is a 7 billion dollar market, correct?

Hey big blue and st jude, what do you have even close to this?

At least Boston has a punchers chance.......

 

[Anonymous]

http://www.biotronik.com/files/95F5AC507236018CC12578CC00523A72/$FILE/PR_BIOFLOW-II_EN_final.pdf

Bottom line, this is 2ish years on the market in Europe and after trying paclitaxel, the bioabsorble orsior is a sirolimus(market leading DES) system.

This is a 7 billion dollar market, correct?

Hey big blue and st jude, what do you have even close to this?

At least Boston has a punchers chance.......

That's almost 2 years old dickweed.
Here's the outcome;

German medical device maker Biotronik touted early findings from a 1st-in-man study of its Dreams absorbable drug-eluting stent, with researchers reporting a mixed bag of findings for the device.

The Dreams stent proved safe at 1 year following the procedure, but wasn't up to par with some rival devices, researchers noted

 

[Anonymous]

http://www.biotronik.com/files/95F5AC507236018CC12578CC00523A72/$FILE/PR_BIOFLOW-II_EN_final.pdf

Bottom line, this is 2ish years on the market in Europe and after trying paclitaxel, the bioabsorble orsior is a sirolimus(market leading DES) system.

This is a 7 billion dollar market, correct?

Hey big blue and st jude, what do you have even close to this?

At least Boston has a punchers chance.......

What an idiot!!!

 

[Anonymous]

http://www.biotronik.com/files/95F5AC507236018CC12578CC00523A72/$FILE/PR_BIOFLOW-II_EN_final.pdf

Bottom line, this is 2ish years on the market in Europe and after trying paclitaxel, the bioabsorble orsior is a sirolimus(market leading DES) system.

This is a 7 billion dollar market, correct?

Hey big blue and st jude, what do you have even close to this?

At least Boston has a punchers chance.......

Eventhough CP is primarily for entertainment purposes in my view, as a fellow BIO Rep, I find this post ridiculous.

Citing CE Approval for a product as somehow impacting its pending FDA Approval isn't supported very well...take for example our MRI Safe CRM products? We were still beat to market by MDT with that crap Kappa Retread.

As for who will be first to market bioabsorbable in the US? My money is on Abbott....particularly because the FDA is going to look at Abbott's application and think....here's a company that has a tried and true track record of quality interventional products IN THE UNITED STATES. Biotronik's OUS data will not hold the same weight. In fact I doubt we'll see a US BMS approved for another couple of years, and then we have to cross our fingers that that launch goes smooth, and does nothing to slow up the subsequent bioabsorbable application.